Laboratory Monitoring Frequency for Patients on Furosemide

Initial Treatment Phase

Check labs 1-2 weeks after starting furosemide or after any dose change, as recommended by the British Journal of Pharmacology and European Journal of Heart Failure 1, 2
For cirrhotic patients with ascites on diuretics, serial measurements of serum creatinine, sodium, and potassium are warranted, especially during the first month of treatment, according to the Journal of Hepatology 3
Regular monitoring of symptoms, urine output, renal function, and electrolytes is essential during IV diuretic use, as stated by the European Journal of Heart Failure 2

Check labs every 4 months, as recommended by the European Society of Cardiology (ESC) 1
Check labs every 6 months, as recommended by the National Institute for Health and Care Excellence (NICE) 1

Patients with severe symptoms or clinical deterioration require monitoring within days to 2 weeks, according to the British Journal of Pharmacology 1

Stop furosemide if severe hypokalemia occurs (<3 mmol/L), as recommended by the Journal of Hepatology 3
Temporarily withdraw diuretics when serum sodium decreases below 120-125 mmol/L, according to the Journal of Hepatology 3
Discontinue if severe hyponatremia (<125 mmol/L), acute kidney injury, worsening hepatic encephalopathy, or incapacitating muscle cramps develop, as stated by the Journal of Hepatology 3